Skip to main content
File #: 21-138    Version: 1
Type: Resolution Status: Ratification
File created: 9/14/2021 In control: Board of Commissioners
On agenda: 10/26/2021 Final action: 10/26/2021
Title: On-Site COVID-19 Testing
Attachments: 1. Administrative Review Form IFB 2021-020, 2. Bid Talley Sheet, 3. Procurement Summary - IFB 2021-020, 4. Solicitation Request Routing Sheet, 5. On-Site COVID-19 Testing
Related files: 22-052

title

On-Site COVID-19 Testing

end

DESCRIPTION: Authorization to award contract to ProPhase Labs Inc. for on-site COVID-19 testing for RTA employees and contractors

AGENDA NO: 21-138

ACTION REQUEST: Approval     Review Comment  Information Only    Other

 

RECOMMENDATION:

recommendation

To authorize the Chief Executive Officer to award a contract to ProPhase Labs, Inc. for on-site COVID-19 testing for all RTA employees and contractors as outlined in the Invitation for Bids (IFB) No. 2021-020.

end

ISSUE/BACKGROUND:

body

RTA continues to implement and maintain a multi-tiered approach to mitigating the overall level of risk of illness/exposure to COVID-19 for its employees and contractors. Staff believes procurement and deployment of external on-site testing resources at each of its facilities serve to further protect the health and wellbeing of workers and their families. The Centers for Disease Control (CDC), Occupational Safety and Health Administration (OSHA), Federal Transit Administration (FTA), and American Public Transportation Association (APTA) have all endorsed regular COVID testing as a specific protective measure for transit agencies to take, combined with requiring masks, promoting/requiring vaccines among workers, and promoting physical distancing and remote work arrangements, to help curb the spread of SARS-CoV-2, the coronavirus that causes COVID-19.

end

DISCUSSION:

RTA has established a need for external COVID-19 testing to further protect employees and contractors from exposure to the SARS-CoV-2 virus which causes COVID-19. In addition to other protective measures taken by RTA management such as masks, mandated COVID-19 vaccines for its employees, and promoting physical distancing at its facilities, providing regular testing will help identify symptomatic as well as asymptomatic COVID-positive individuals before they come into contact with fellow employees, customers, and the general public throughout the system.

FINANCIAL IMPACT:

The cost for this procurement is estimated to be $242,400.00 for a two-month period of deployment. It will be funded through CARES Act funding.

NEXT STEPS:

Upon RTA Board approval, an award letter will be issued to ProPhase Labs, Inc. and a purchase order will be executed. An on-site kick-off meeting will be held with vendor representatives and RTA staff.

ATTACHMENTS:

1.                     Board Resolution

2.                     Administrative Review Form IFB 2021-020

3.                     Bid Tally Sheet

4.                     Procurement Summary - IFB 2021-020

5.                     Solicitation Request Routing Sheet

 

 

Prepared By:                                          Korrie Mapp

Title:                                                               Director of Occupational Safety & Health

                     

                                          

Reviewed By:                     Michael J. Smith

Title:                                                               Chief Safety Officer

 

Reviewed By:                     Gizelle Johnson Banks

Title:                                                               Chief Financial Officer

 

 

 

 

 

                                                               9/23/2021

Alex Wiggins                                                                                                                              Date

Chief Executive Officer